APA (7th ed.) Citation

N, S., M, B. D., N, Z., R, T., A, H. S., E, B., . . . T, B. (2024). Short-term efficacy of vedolizumab in patients with inflammatory bowel disease in real-life settings in Bosnia and Herzegovina. Biomolecules & biomedicine, 24(5), 1400. https://doi.org/10.17305/bb.2024.10433

Chicago Style (17th ed.) Citation

N, Salkić, et al. "Short-term Efficacy of Vedolizumab in Patients with Inflammatory Bowel Disease in Real-life Settings in Bosnia and Herzegovina." Biomolecules & Biomedicine 24, no. 5 (2024): 1400. https://doi.org/10.17305/bb.2024.10433.

MLA (9th ed.) Citation

N, Salkić, et al. "Short-term Efficacy of Vedolizumab in Patients with Inflammatory Bowel Disease in Real-life Settings in Bosnia and Herzegovina." Biomolecules & Biomedicine, vol. 24, no. 5, 2024, p. 1400, https://doi.org/10.17305/bb.2024.10433.